Merck rose 1.97% to Rs 686 at 11:41 IST on BSE after net profit rose 27.3% to Rs 12.25 crore on 12.2% growth in net sales to Rs 212.90 crore in Q1 March 2016 over Q1 March 2015.
The company declared its results after trading hours yesterday, 12 May 2016.Meanwhile, the S&P BSE Sensex was down 229.31 points or 0.89% at 25,560.91
On BSE, so far 5,280 shares were traded in the counter as against average daily volume of 3,118 shares in the past one quarter. The stock hit a high of Rs 696 and a low of Rs 676.25 so far during the day. The stock had hit a 52-week high of Rs 904 on 6 August 2015. The stock had hit a 52-week low of Rs 623 on 12 February 2016. The stock had outperformed the market over the past one month till 12 May 2016, rising 3.74% compared with 2.56% rise in the Sensex. The scrip, however, underperformed the market in past one quarter, rising 6.24% as against Sensex's 12.20% rise.
The small-cap company has equity capital of Rs 16.60 crore. Face value per share is Rs 10.
Merck is a leading science and technology company in healthcare, life science and performance materials.
Powered by Capital Market - Live News
